Dale Chappell
- Co-authors
- Adrian KilcoyneCameron DurrantOmar AbdihamidFrank CerasoliVictoria M. CattersonChristopher PolkAndrew D. BadleyAllen S. Zhou
- Topics
- COVID-19 Clinical Research Studies (6 papers)Long-Term Effects of COVID-19 (4 papers)CAR-T cell therapy research (3 papers)
- Cited by
- Infectious DiseasesNeurologyOncology
- Journals
- SHILAP Revista de lepidopterologíaBloodCHEST Journal
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Dale Chappell
9 papers receiving 32 citations
Peers
Comparison fields: 5 of 26
- Infectious Diseases 15
- Oncology 13
- Neurology 9
- Economics and Econometrics 6
- Molecular Biology 5
Countries citing papers authored by Dale Chappell
This map shows the geographic impact of Dale Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale Chappell more than expected).
Fields of papers citing papers by Dale Chappell
This network shows the impact of papers produced by Dale Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale Chappell. The network helps show where Dale Chappell may publish in the future.
Co-authorship network of co-authors of Dale Chappell
This figure shows the co-authorship network connecting the top 25 collaborators of Dale Chappell. A scholar is included among the top collaborators of Dale Chappell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dale Chappell. Dale Chappell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England | 3 |
| 2 | 8 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 3 | |
| 9 | 3 | |
| 10 | 3 | |
| 11 | 3 |
About Dale Chappell
Dale Chappell is a scholar working on Infectious Diseases, Neurology and Critical Care and Intensive Care Medicine, having authored 11 papers that have together received 34 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Long-Term Effects of COVID-19 (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Infectious Diseases (15 citations), Neurology (9 citations) and Oncology (13 citations). Dale Chappell has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Adrian Kilcoyne, Cameron Durrant, Omar Abdihamid, Frank Cerasoli, Victoria M. Catterson, Christopher Polk, Andrew D. Badley, Allen S. Zhou, Saad S. Kenderian and Amalia Tsiami. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.